Skip to main content
Premium Trial:

Request an Annual Quote

Lonza, Bar Harbor Biotech Expand Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bar Harbor BioTechnology and Lonza have expanded their distribution partnership to include new qPCR array tools, Lonza said today.

The companies first struck an exclusive distribution agreement in 2008 that covered the StellARray Gene Expression System, which is used by researchers to accurately detect small changes in gene expression or to measure copy number variations. Lonza will now distribute the system along with the Global Pattern Recognition 2.0 software, Custom Plate Designer, and XenoQ products, which were launched in January.

Lonza's Research Solutions Director of Product Marketing Dietmar Pein said that expression profiling by qPCR arrays, particularly when used in combination with new solutions that address normalization and customization challenges, will become more important in life sciences research.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.